Chinese game live-streaming platform Douyu International Holdings closed flat on its first day of trading on NASDAQ following a $775 million IPO – the largest US offering by a Chinese company this year.
Chinese cloud-based robotics developer CloudMinds has filed for an IPO in the US with a view to raising up to $500 million.
Southeast Asia’s internal growth and rising appeal among global investors in recent years have fed expectations that PE and VC exits will follow. The logic is sturdy but detailed projections are elusive
Second quarter analysis: Spin-outs reflect challenges for China fundraising; weak buyout activity continues to hold back Asia PE investment; Korea heads the exit charts as China falls back
Feihe, a China-based dairy products manufacturer backed by Morgan Stanley Private Equity Asia (MSPEA), has filed for an IPO in Hong Kong.
Home Control International, a Singapore-based manufacturer of remote controls for television and smart devices owned by Morgan Stanley Private Equity Asia (MSPEA), has filed for an IPO in Hong Kong.
AMTD International, the investment banking, asset management, and strategic investment division of Hong Kong-based financial advisor AMTD Group, has filed for an IPO in the US. Both companies are backed by Morgan Stanley Private Equity Asia (MSPEA).
Hansoh Pharmaceutical Group, a Chinese drug developer that counts Hillhouse Capital and Boyu Capital among its investors, has raised HK$7.86 billion ($1 billion) through a Hong Kong IPO.
Pan-Asian logistics and fund management platform ESR has postponed its Hong Kong IPO, which was expected to raise up to HK$975.6 billion ($1.24 billion) and facilitate partial exits for several private equity investors.
Private equity-backed online real estate portal Fang.com has spun-out its property analytics and benchmarking system in what its CEO Yu Huang described as the first direct public offering (DPO) by a Chinese company in the US.
GSX Techedu, operator of Chinese online education platform Baijiahulian, raised $207.9 million in its US IPO, but a flat first day of trading was followed by a 4.6% decline on day two.
Mabpharm, a China-based biopharmaceutical company backed by CDH Investments, saw its stock drop almost 20% on debut following a HK$1.23 billion ($157 million) IPO in Hong Kong.
Frontage Holdings, a China-based contract research organization (CRO), has raised HK$1.61 billion ($205.1 million) in its Hong Kong IPO, having received support from several private equity investors.
Meten International Education Group, a Chinese online-to-offline (O2O) English language training provider that mainly caters to adult students, has filed for a US IPO. DG Capital is the primary PE investor in the company.
China’s second largest coffee chain Luckin Coffee, which counts Centurium Capital and Joy Capital among its private equity investors, surged around 20% on its US debut following a $561 million IPO.
Sansan, a PE-backed company that specializes in cloud-based business card digitization, has filed for a domestic IPO that is expected to generate around JPY35.2 billion ($321 million).
Vietnam’s economic future is tied to an attractive but immature and constrained banking sector. Investors are prodding the edges of a precarious opportunity set
Baijiahulian, a Chinese online education platform that provides after-school tutoring services for primary and secondary school students, has filed for a US IPO. The company’s backers include Gaorong Capital.
Duiba, operator of a China-based interactive advertising platform and software-as-a-service (SaaS) management system for online businesses, traded flat on its Hong Kong debut, following an IPO of HK$766.2 million($97.6 million).
Yunji, a Chinese membership-based e-commerce platform, gained 29% on its NASDAQ trading debut following a $121 million IPO that was largely covered by two of its private equity investors.
So-Young International, a Chinese online marketplace specializing in cosmetic surgery, surged over 33% on its trading debut following a $166.8 million IPO on NASDAQ.
Tot Biopharm, a private equity-backed Chinese cancer drug developer, has filed for a Hong Kong IPO under rules that allow for listings by pre-revenue biotech companies.
Affinity Equity Partners is set to make a partial exit from Leong Hup International as the Malaysian poultry producer looks to raise up to MYR1.19 billion ($288 million) in a domestic IPO.
Douyu International Holdings, a Chinese live-streaming platform that provides coverage of online gaming, has announced plans for a US listing. The company’s investors include Sequoia Capital China and Tencent Holdings.